Scenario 1: A 47-Year-Old Man With Intermediate Risk Metastatic RCC
Expert perspectives on a patient scenario of intermediate risk metastatic renal cell carcinoma and corresponding management with combination immunotherapy.
Source: onclive.com
Page 7 - Optimizing Outcomes News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Optimizing Outcomes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Optimizing Outcomes Today - Breaking & Trending Today
Augmenting Antidepressants With Aripiprazole Improves Symptoms in TRD
Augmenting antidepressant therapy with aripiprazole is associated with favorable outcomes in older patients with TRD.
Source: neurologyadvisor.com
Augmenting Antidepressants With Aripiprazole Improves Symptoms in TRD
Augmenting antidepressant therapy with aripiprazole is associated with favorable outcomes in older patients with treatment-resistant depression.
Source: psychiatryadvisor.com
Antidepressant augmentation associated with improved outcomes in treatment-resistant geriatric depression
1. In older adults with treatment-resistant depression, aripiprazole-augmentation significantly improved psychological outcomes compared to bupropion-augmentation or switching to bupropion. 2. In older adults with treatment-resistant depression, bupropion-augmentation was associated with a greater risk for falls than aripiprazole-augmentation. Evidence Rating Level: 1 (Excellent) Study Rundown: Major depressive disorder (MDD) is a common condition among older adults
Source: 2minutemedicine.com
Report: Marketers lack confidence in media and advertising measurement, optimisation and targeting
New CMO Council report shows many marketers lacking confidence in their ability to harness the data and agility needed to drive media and advertising campaign effectiveness
Source: cmo.com.au